Transfection implies to a process of introducing genetic material such as DNA or RNA into eukaryotic cells to enable the production or expression of proteins using the cell’s own machinery. A double stranded RNA transfection is employed to stop the production of certain proteins by hindering the translation process.

Drivers & Restraints

The global market is anticipated to rise at a considerable rate during the forecast period. In the recent years, the market was growing at a steady rate and with the rising adoption of strategies by key players; the market is expected to rise over the projected horizon. This growth can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery.

Sample Link Here:






Particle Bombardment


Adenoviral Vectors



Gene Expression Studies

Protein Production

Transgenic Models

Therapeutic Delivery

Cancer Research

Biomedical Research


Regional Analysis

The market has been segment into North America, South America, Europe, Asia-Pacific, and Middle East and Africa. North America is expected to account for the largest share of the transfection reagent market, followed by Europe and Asia-Pacific.

Purchase Link Here:



Thermo Fisher Scientific, Inc.

Promega Corporation



  1. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories Inc

Merck KGaA




Shawn Kelvin

Source link